mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.02 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.02 |
mRNA |
BRD1835 |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.02 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.02 |
mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.02 |
mRNA |
BRD-K11533227 |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.02 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.02 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.02 |
mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.03 |
mRNA |
semagacestat |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.03 |